Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In this study we used stool profiling to identify intestinal bacteria and metabolites that are differentially represented in humans with colorectal cancer (CRC) compared to healthy controls to identify how microbial functions may influence CRC development. Stool samples were collected from healthy adults (n = 10) and colorectal cancer patients (n = 11) prior to colon resection surgery at the University of Colorado Health-Poudre Valley Hospital in Fort Collins, CO. The V4 region of the 16s rRNA gene was pyrosequenced and both short chain fatty acids and global stool metabolites were extracted and analyzed utilizing Gas Chromatography-Mass Spectrometry (GC-MS). There were no significant differences in the overall microbial community structure associated with the disease state, but several bacterial genera, particularly butyrate-producing species, were under-represented in the CRC samples, while a mucin-degrading species, Akkermansia muciniphila, was about 4-fold higher in CRC (p<0.01). Proportionately higher amounts of butyrate were seen in stool of healthy individuals while relative concentrations of acetate were higher in stools of CRC patients. GC-MS profiling revealed higher concentrations of amino acids in stool samples from CRC patients and higher poly and monounsaturated fatty acids and ursodeoxycholic acid, a conjugated bile acid in stool samples from healthy adults (p<0.01). Correlative analysis between the combined datasets revealed some potential relationships between stool metabolites and certain bacterial species. These associations could provide insight into microbial functions occurring in a cancer environment and will help direct future mechanistic studies. Using integrated "omics" approaches may prove a useful tool in identifying functional groups of gastrointestinal bacteria and their associated metabolites as novel therapeutic and chemopreventive targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a few cross-sectional studies reported that patients with CRC had a lower abundance of butyrate-producing species and lower fecal levels of butyrate than controls (Table 1).97, 133–135”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [97]
In the citing paper
“Nevertheless, A. muciniphila has previously been linked to an increased burden of CRC in human and mice,25–27”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“A healthy gastrointestinal system relies on a balanced commensal biota to regulate processes such as dietary energy harvest [1], metabolism of microbial and host derived chemicals [2], and immune modulation [3].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 2×
“Prevotella was a dominant genera reported in stool from children in a rural community in Burkina Faso but absent from a cohort of Italian children, and the study authors hypothesized that Prevotella helped maximize energy harvest from a plant-based diet [29].”
BackgroundSmith, C. A., Want, E. J., O'Maille, G., Abagyan, R., & Siuzdak, G. (2006) · Analytical Chemistry · doi:10.1021/ac051437y · Cited by 5,262
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Nicholson, J. K., & Lindon, J. C. (2008) · Nature · doi:10.1038/4551054a · Cited by 1,886
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 2×
“This bacterium is a common member of the colonic microbiota and was recently shown to be reduced in irritable bowel syndrome and Crohn’s Disease [32]; however a more recent report showed increased A. muciniphila in ulcerative colitis-associated pouchitis [33].”
Background
Research works printed but not linked: 1
- J Byrd, 2004, Mucins and mucin binding proteins in colorectal cancer, Cancer and Metastasis Reviews, 23, 77, 10.1023/A:1025815113599 · DOI · Paper page
Cited by
Items 401–500 of 642
Zhang, H., Wu, J., Ji, D., Liu, Y., Lu, S., Lin, Z., Chen, T., & Ao, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1005201 · Cited by 20
“found that butyric acid was significantly higher in the feces of healthy individuals (Weir et al., 2013).”
BackgroundLuminally expressed gastrointestinal biomarkers
Cummins, G., Yung, D. E., Cox, B. F., Koulaouzidis, A., Desmulliez, M. P. Y., & Cochran, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1373017 · Cited by 17
Consumption of Cooked Navy Bean Powders Modulate the Canine Fecal and Urine Metabolome
Forster, G. M., Heuberger, A. L., Broeckling, C. D., Bauer, J. E., & Ryan, E. P. (2015) · Current Metabolomics · doi:10.2174/2213235x03666150519234354 · Cited by 18
Yang, S., Wang, Y., Sheng, L., Cui, W., & Ma, C. (2025) · Scientific Reports · doi:10.1038/s41598-024-84801-6 · Cited by 20
The animal's microbiome and cancer: A translational perspective
Aluai‐Cunha, C., Pinto, C. A., Correia, A., Serra, C. R., & Santos, A. A. F. (2023) · Veterinary and Comparative Oncology · doi:10.1111/vco.12892 · Cited by 17
Ethanologenesis from glycerol by the gut acetogen Blautia schinkii
Trischler, R., Poehlein, A., Daniel, R., & Müller, V. (2023) · Environmental Microbiology · doi:10.1111/1462-2920.16517 · Cited by 14
The human volatilome meets cancer diagnostics: past, present, and future of noninvasive applications
Barbosa, J. M. G., & Filho, N. R. A. (2024) · Metabolomics · doi:10.1007/s11306-024-02180-5 · Cited by 18
“, who demonstrated the implications of volatile-microbiome cross-talk in colorectal cancer (Weir et al., 2013), which was later confirmed by other studies (Bond et al., 2019; Katsaounou et al., 2023; McFarlane et al., 2019; Niccolai et al., 2019; Śmiełowska et al., 2023).”
Gut microbiome in colorectal cancer: metagenomics from bench to bedside
Esfahani, A. T., Zafarjafarzadeh, N., Vakili, F., Bizhanpour, A., Mashaollahi, A., Kordestani, B. K., Baratinamin, M., & Mohammadpour, S. (2025) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaf026 · Cited by 19
Chemopreventive Potential of Probiotics and Prebiotics
Sunkata, R., Herring, J., Walker, L. T., & Verghese, M. (2014) · Food and Nutrition Sciences · doi:10.4236/fns.2014.518194 · Cited by 17
“[25] Weir, T.”
Li, G., Li, W., Song, B., Wang, C., Shen, Q., Li, B., Tang, D., Xu, C., Geng, H., Gao, Y., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/25342 · Cited by 21
Miura, H., Mukai, K., Sudo, K., Haga, S., Suzuki, Y., Kobayashi, Y., & Koike, S. (2021) · Journal of Animal Science · doi:10.1093/jas/skab012 · Cited by 16
Sample treatment optimization for fish stool metabolomics
Hano, T., Ito, M., Ito, K., & Uchida, M. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.06.014 · Cited by 15
Ortega-Vega, E. L., Guzmán-Castañeda, S. J., Campo, O., Velásquez-Mejía, E. P., de la Cuesta‐Zuluaga, J., Bedoya, G., & Escobar, J. S. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1619440 · Cited by 19
The Gut Microbiome and Pediatric Cancer: Current Research and Gaps in Knowledge
Bhuta, R., Nieder, M. L., Jubelirer, T. F., & Ladas, E. J. (2019) · JNCI Monographs · doi:10.1093/jncimonographs/lgz026 · Cited by 16
Clavenna, M. G., Vecchia, M. L., Sculco, M., Joseph, S., Barberis, E., Amede, E., Mellai, M., Brossa, S., Borgonovi, G., Occhipinti, P., et al. (2023) · Cancers · doi:10.3390/cancers15123065 · Cited by 14
“Interestingly, Pelomonas is associated with the onset of multifocal atrophic gastritis and intestinal metaplasia, well established premalignant gastro-intestinal lesions [46], and is enriched in LAM of CRC patients receiving chemotherapy and/or radiotherapy treatment [47], while Phascolarctobacterium is enriched in st…”
BackgroundZhang, Y., Dong, L., Dai, X., Huang, Y., Gao, Y., & Wang, F. (2024) · Discover Oncology · doi:10.1007/s12672-024-00897-2 · Cited by 16
Ai, D., Pan, H., Li, X., Wu, M., & Xia, L. C. (2019) · PeerJ · doi:10.7717/peerj.7315 · Cited by 18
“For examples, in the metabolic disorders, such as IBD or obesity, the changes in gut microbiota cause a state of imbalance in metabolic activity and lead to the diseases (Chang et al., 2015; Tsuda et al., 2010; Weir et al., 2013).”
BackgroundBerbert, L., Santos, A., Magro, D. O., Guadagnini, D., Assalin, H. B., Lourenço, L. H., Martinez, C. A. R., Saad, M. J. A., & Coy, C. S. R. (2022) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2022e11832 · Cited by 16
“Acidaminobacter was also found to be overrepresented in CRC stool samples (22).”
BackgroundZhou, P., Zhang, W., Liao, Y., Zhai, Z., Lu, S., Jiang, S., Hu, W., & Gong, W. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002573 · Cited by 18
Clinical applications of volatilomic assays
Capuano, R., Ciotti, M., Catini, A., Bernardini, S., & Natale, C. D. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2024.2387038 · Cited by 14
“Several studies using GC-MS observed increased levels of some amino acids and short chain fatty acids, whereas bile acids and polyol alcohols decreased [227].”
Smart Polymer‐Based Delivery Systems for Curcumin in Colon Cancer Therapy: A Review
Kamath, A. J., Donadkar, A. D., Nair, B., Kumar, A. R., Sabitha, M., Sethi, G., Chauhan, A. S., & Nath, L. R. (2024) · Phytotherapy Research · doi:10.1002/ptr.8394 · Cited by 15
“The bacteria in the colonic micro-flora include the Clostridium species and the genus Bacteroides , Pseudo streptococcus , and Eubacteria , Lactobacilli (Canny and McCormick 2008; Weir et al. 2013).”
Mazewski, C., Luna‐Vital, D. A., Berhow, M. A., & de Mejı́a, E. G. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa008 · Cited by 14
Leng, Y., Jiang, C., Xing, X., Tsai, M.-S., Snyder, M. P., Zhai, A., & Yao, G. (2020) · Shock · doi:10.1097/shk.0000000000001593 · Cited by 15
“reported that it is significantly more abundant in healthy adults compared with patients with colorectal cancer (48).”
BackgroundIntestinal Organoids: A Model to Study the Role of Microbiota in the Colonic Tumor Microenvironment
Nalluri, H., Subramanian, S., & Staley, C. M. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0345 · Cited by 13
Strategies for the treatment of colorectal cancer caused by gut microbiota
de Souza, J. B., de Castro, M. C. A. B., & Cavalcanti, I. M. F. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120202 · Cited by 15
Mechanistic and Technical Challenges in Studying the Human Microbiome and Cancer Epidemiology
Verma, M. (2016) · Technology in Cancer Research & Treatment · doi:10.1177/1533034616645219 · Cited by 14
The role of the colonic microbiota and bile acids in colorectal cancer
Roberts, D. C., Chidambaram, S., & Kinross, J. K. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000816 · Cited by 14
“A diet rich in saturated fat promoted conjugation of CA with taurine and resulted in more sulphite-reducing Bilophila wadsworthia to regulate the increased luminal levels of sulphur substrate [72,73].”
BackgroundEditorial on "Cancer and the microbiota" published in Science.
Hamm, A. K., & Weir, T. L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.07.16 · Cited by 16
“Depletion of butyrate has been noted in humans with colorectal cancer (10) and other inflammatory bowel conditions (43).”
BackgroundLi, X., Jia, Y., Li, Y., Hei, H., Zhang, S., & Qin, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582166 · Cited by 16
“In addition to their individual roles in physiological and pathological processes, the interaction between microbiota and the metabolic reprogramming has emerged as a critical factor in tumorigenesis and therapeutic response (21, 22).”
The pathobiont role of Akkermansia muciniphila in colorectal cancer: a systematic review
Soheilipour, M., Noursina, A., Nekookhoo, M., Malekpour, E., Mirzaei, S. A., Shafieyoun, M. H., Rouzbahani, H., Chitsazi, M. R., & Safari, F. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04293-0 · Cited by 18
“Fecal samples typically show increased A. muciniphila in CRC patients [22, 43], while mucosal biopsies present complex patterns [31, 41].”
Shi, J., Shen, H., Huang, H., Zhan, L., Chen, W., Zhou, Z., Lv, Y., Xiong, K., Jiang, Z., Chen, Q., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1395514 · Cited by 14
Xu, M., Qin, Y., Xia, Y., Wang, G., Xiong, Z., Song, X., & Ai, L. (2024) · Food & Function · doi:10.1039/d4fo03133d · Cited by 14
Garavaglia, B., Vallino, L., Ferraresi, A., Visciglia, A., Amoruso, A., Pane, M., Munteanu, C., & Isidoro, C. (2025) · Biomedicines · doi:10.3390/biomedicines13071554 · Cited by 16
“In patients with CRC, there is a marked reduction in butyrate levels, a condition predisposing to intestinal permeability, increased inflammation, and dysbiosis [161,162].”
Metabolome responses of Enterococcus faecium to acid shock and nitrite stress
Yu, Z., Shi, D., Liu, W., Meng, Y., & Meng, F. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27497 · Cited by 12
“The investigations of stool metabolite profiles can provide a more direct evidence of the metabolic activities of some gut bacteria under conditions of exogenous stress (Jacobs et al., 2008; Weir et al., 2013).”
BackgroundProbiotic immunonutrition impacts on colon cancer immunotherapy and prevention
Nami, Y., Hejazi, S., Geranmayeh, M. H., Shahgolzari, M., & Khosroushahi, A. Y. (2022) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000738 · Cited by 14
Global trends in Akkermansia muciniphila research: A bibliometric visualization
Li, Z., Ke, H., Wang, Y., Chen, S., Liu, X., Lin, Q., Wang, P., & Chen, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1037708 · Cited by 15
Hes, C., & Jagoe, R. T. (2023) · BJC Reports · doi:10.1038/s44276-023-00008-8 · Cited by 16
“In those patients the relative abundances of Fusobacterium [31, 32, 40, 41], Porphyromonas [31, 32, 40] and A. muciniphila [32, 42] are increased, and F. prausnitzii is decreased compared to healthy controls [32, 41].”
BackgroundCacciola, N. A., Venneri, T., Salzano, A., D’Onofrio, N., Martano, M., Saggese, A., Vinale, F., Neglia, G., Campanile, C., Baccigalupi, L., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01271-5 · Cited by 15
“Interestingly, high Akkermansia levels were found in CRC patients compared to healthy individuals and increased after chemotherapy, suggesting a positive correlation with therapeutic effect [78, 79].”
BackgroundINTESTINAL MICROBIOTA MUTUALISM AND GASTROINTESTINAL DISEASES
Tomasello, G., Sinagra, E., Zeenny, M., Jurjus, A. R., Giammanco, M., Majo, D. D., Traina, G., Damiani, P., Zein, R. J., & Leone, A. (2026) · EuroMediterranean Biomedical Journal · doi:10.3269/1970-5492.2015.10.1 · Cited by 15
Méndez–García, C., Barbas, C., Ferrer, M., & Rojo, D. (2017) · Journal of Bacteriology · doi:10.1128/jb.00376-17 · Cited by 13
Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies
Kang, Y., Pan, W. D., & Cai, Y. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0043-116387 · Cited by 13
“, Ruminococcus obeum, Ruminococcus albus, Pseudobutyrivibrio ruminis) were lower while the abundance of Akkermansia muciniphila (a mucin-degrading species) was about quadruple higher in stool samples from CRC patients [45].”
BackgroundJavid, H., Karimi‐Shahri, M., Khorramdel, M., Mashhad, A. S., Tabrizi, A. T., Sathyapalan, T., Afshari, A. R., & Sahebkar, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220511185745 · Cited by 16
Ghosh, J., Schultz, B. M., Chan, J., Wultsch, C., Singh, R., Shureiqi, I., Chow, S., Doymaz, A., Varriano, S., Driscoll, M., et al. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0258 · Cited by 13
Manna, L., Rizzi, E., Bafile, E., Cappelleri, A., Ruscica, M., Macchi, C., Vulpiani, M. P., Salini, R., Rossi, E., Panebianco, C., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1072334 · Cited by 13
“Among other interesting changes, Acidaminobacter, which is increased in colorectal cancer patients (55), was detected in all time-point of G3 but was completely absent in Paniculin 13TM -supplemented G4.”
BackgroundChoi, S. I., Kim, N., Choi, Y., Nam, R. H., Jang, J. Y., & Cho, S. (2024) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm23096 · Cited by 16
Microbes in the tumor microenvironment: New additions to break the tumor immunotherapy dilemma
Zhou, L., Fan, S., Zhang, W., Wang, D., & Tang, D. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127777 · Cited by 13
Ethnicity influences gut metabolites and microbiota of the tribes of Assam, India
Dehingia, M., Sen, S., Bhaskar, B., Joishy, T. K., Deka, M., Talukdar, N. C., & Khan, M. R. (2017) · Metabolomics · doi:10.1007/s11306-017-1206-y · Cited by 12
An Evaluation of the Fecal Microbiome in Lynch Syndrome
Gonzalez, A. J., Kapila, N., Melendez-Rosado, J., Liang, H., & Castro, F. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00588-z · Cited by 11
Bi-direction effects between microbiome and MiRNAs in carcinogenesis
Wang, Q., Ding, H., Dong, G., Xu, L., Jiang, F., & Mao, Q. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03567-w · Cited by 11
“nucleatum infection could promote prometastatic behaviors in CRC via selective delivery of miR-1246/92b- 3p/27a- 3p- enriched exosomes to uninfected cells (Weir et al. 2013).”
BackgroundGarcia, A. R., Hurley, K. A., Marastoni, G., Diard, M., Hofer, S., Greppi, A., Hardt, W., Lacroix, C., Sturla, S. J., & Schwab, C. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00137 · Cited by 11
All That Glitters Ain’t Gold: The Myths and Scientific Realities About the Gut Microbiota
Dey, P. (2025) · Nutrients · doi:10.3390/nu17193121 · Cited by 13
“Nevertheless, it also presents an emerging cautionary tale, indicating that its effects may differ based on contextual factors [29–31].”
Yang, S., Hao, S., Ye, H., & Zhang, X. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1083987 · Cited by 10
“Some studies (Wang T. et al., 2012; Weir et al., 2013; Wu et al., 2013) have shown that a significant reduction in butyrate-producing bacteria and an increase in opportunistic pathogens may constitute the main IM imbalance in patients with CRC.”
BackgroundInfluentialSenthakumaran, T., Tannæs, T. M., Moen, A. E. F., Brackmann, S. A., Jahanlu, D., Rounge, T. B., Bemanian, V., & Tunsjø, H. S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13700 · Cited by 11
Effects and mechanisms of Helicobacter pylori on cancers development and immunotherapy
Zhong, X., Zheng, H., Zhao, S., Wang, Z., Su, Y., Zhong, K., Wang, M., & Shi, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1469096 · Cited by 12
KRAS G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation
Budagyan, K., Cannon, A. C., Chatoff, A. G., Benton, D., Kurimchak, A., Araiza‐Olivera, D., Gerasimova, A., Snyder, N. W., Duncan, J. S., Uribe‐Alvarez, C., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115444 · Cited by 15
Microbial Markers in the Diagnosis of Colorectal Cancer: The Promise, Reality and Challenge
DeSantis, T. Z., Shah, M. S., Cope, J. L., & Hollister, E. B. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0185 · Cited by 11
The Regional Specificity of Mucosa-Associated Microbiota in Patients with Distal Colorectal Cancer
Kono, Y., Inoüe, R., Teratani, T., Tojo, M., Kumagai, Y., Morishima, S., Koinuma, K., Lefor, A. K., Kitayama, J., Sata, N., et al. (2021) · Digestion · doi:10.1159/000519487 · Cited by 12
The nexus of gut microbiota, diet, and health
Bhattarai, S., & Janaswamy, S. (2022) · Functional Food Science · doi:10.31989/ffs.v2i2.885 · Cited by 16
“HIV Clostridia Bacteroidia Lactobacilli Bifidobacteria [21, 56, 60-62]”
BackgroundPea Starch-Lauric Acid Complex Alleviates Dextran Sulfate Sodium-Induced Colitis in C57BL/6J Mice
Qin, N., Meng, Y., Ma, Z., Li, Z., Hu, Z., Zhang, C., & Chen, L. (2023) · Nutrition and Cancer · doi:10.1080/01635581.2023.2223789 · Cited by 11
“animal models and patients with colorectal cancer and was positively associated with the severity of UC (52, 53).”
BackgroundWhat influences preneoplastic colorectal lesion recurrence?
Maio, G. D., Zama, E., Rengucci, C., & Calistri, D. (2016) · Oncotarget · doi:10.18632/oncotarget.13628 · Cited by 10
Ning, W., Li, H., Meng, F., Cheng, J., Song, X., Zhang, G., Wang, W., Wu, S., Fang, J., Ma, K., et al. (2017) · Biomedical Chromatography · doi:10.1002/bmc.3999 · Cited by 12
Yimagou, E. K., Baudoin, J., Abdallah, R. A., Pinto, F. D., Khalil, J. B., & Raoult, D. (2020) · The Journal of Microbiology · doi:10.1007/s12275-020-9365-3 · Cited by 10
Ghanavati, R., Mohammadi, F., Javadi, A., Shahosseini, Z., Talebi, M., & Rohani, M. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100207 · Cited by 9
Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk
Barry, E. L., Fedirko, V., Uppal, K., Ma, C., Liu, K., Mott, L. A., Peacock, J. L., Passarelli, M. N., Baron, J. A., & Jones, D. P. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0014 · Cited by 11
Watanabe, D., Murakami, H., Ohno, H., Tanisawa, K., Konishi, K., Todoroki-Mori, K., Tsunematsu, Y., Sato, M., Ogata, Y., Miyoshi, N., et al. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02255-6 · Cited by 10
“Previous studies reported that certain plasma fatty acids, including α-linoleic acid [41] and certain fecal SCFAs such as propionate [35] and isovaleric acid [36], were associated with a higher CRC incidence.”
Zamora-Gasga, V. M., Cárdenas-Castro, A. P., Montalvo‐González, E., Loarca-Piña, M. G. F., Vázquez‐Landaverde, P. A., Tovar, J., & Sáyago‐Ayerdi, S. G. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2017.1416458 · Cited by 12
“The presence of these compounds, retained in the non-solid phase of faeces, has led to the use of faecal water to determine the potentially toxic environment to which the lumen is exposed (Weir et al. 2013; Vandeputte et al. 2015).”
BackgroundBhaskar, B., Bhattacharya, A., Adak, A., Das, S., & Khan, M. R. (2023) · Fermentation · doi:10.3390/fermentation9020126 · Cited by 14
Exploring the gut microbiome: A potential biomarker for cancer diagnosis, prognosis, and therapy
Han, E.-J., Ahn, J., Choi, Y.-J., Kim, D.-H., Choi, J.-S., & Chung, H. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189251 · Cited by 12
Arulvasan, W., Greenwood, J., Ball, M. L., Chou, H., Coplowe, S., Birch, O., Gordon, P., Ratiu, A., Lam, E. S., Tardelli, M., et al. (2025) · Metabolomics · doi:10.1007/s11306-024-02218-8 · Cited by 11
“7) (Averina et al., 2020; Cagno et al., 2011; Gall et al., 2011; Gao et al., 2022; Gar-ner et al., 2007; Goedert et al., 2014; Lin et al., 2021; Preter et al., 2015; Raman et al., 2013; Sinha et al., 2016; Walton et al., 2013; Weir et al., 2013).”
Cellular and molecular mechanisms in the pathogenesis of pouchitis: more than just the microbiota
Neto, M. B. B., Qazi, T., Fulmer, C. G., Holubar, S. D., Fiocchi, C., Ivanov, A. I., & Rieder, F. (2025) · Gut · doi:10.1136/gutjnl-2024-334445 · Cited by 11
“62 In addition to the depletion of butyrate in the context of pouchitis, the microbiota can also modulate inflammation through bile acid metabolism deregulation.”
Faecal microbiota transplantation, a promising way to treat colorectal cancer
Ma, Y., & Chen, H. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.015 · Cited by 11
Gut Microbiome: An Intersection between Human Genome, Diet, and Epigenetics
Muhammad, A. Y., Amonov, M., Baig, A. A., & Alvi, F. J. (2024) · Advanced Gut & Microbiome Research · doi:10.1155/2024/6707728 · Cited by 15
Microbial Metabolites in Cancer Promotion or Prevention
Cox‐York, K. A., Stoecker, E., Hamm, A. K., & Weir, T. L. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_15 · Cited by 10
Zhang, K., Dong, Y., Ding, Y., Wang, X., Liu, T., Zhong, W., & Cao, H. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128240 · Cited by 8
Proteomic indicators of oxidation and hydration state in colorectal cancer
Dick, J. M. (2016) · PeerJ · doi:10.7717/peerj.2238 · Cited by 9
Associations between Ileal Juice Bile Acids and Colorectal Advanced Adenoma
Luu, H. N., Tran, C., Wang, R., Nguyen, M. V., Tran, M. T., Tuong, T. T., Tran, Q., Le, L. C., Pham, H., Vu, H. T., et al. (2023) · Nutrients · doi:10.3390/nu15132930 · Cited by 8
“Prior human studies have used fecal samples to report high concentration of LCA [24], and DCA [25,26], and total secondary bile acids in CRC cases versus controls [24].”
BackgroundResultEngineered nanomaterials and the microbiome: Implications for human health
Zickgraf, F. M., Murali, A., & Landsiedel, R. (2023) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2023.100429 · Cited by 9
Katona, B. W., Shukla, A., Hu, W., Nyul, T. E., Dudzik, C. M., Arvanitis, A., Clay, D., Dungan, M. E., Weber, M., Tu, V., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2474141 · Cited by 10
Hajjami, N. E., Moussa, S., Houssa, J., Monteyne, D., Pérez-Morga, D. L., & Botteaux, A. (2017) · MicrobiologyOpen · doi:10.1002/mbo3.520 · Cited by 8
“Random point mutations within MxiI were created by error- prone PCR as described previously (Weir et al., 2013).”
MethodHierarchical non-negative matrix factorization using clinical information for microbial communities
Abe, K., Hirayama, M., Ohno, K., & Shimamura, T. (2021) · BMC Genomics · doi:10.1186/s12864-021-07401-y · Cited by 8
Reevaluating the hype: four bacterial metabolites under scrutiny
Fröhlich, E. E., Mayerhofer, R., & Holzer, P. D. (2014) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi-d-14-00030 · Cited by 9
“[103] reported recently that BA-producing bacteria are reduced in the stool of colorectal cancer patients.”
BackgroundMetabolic characterization and viable delivery of Akkermansia muciniphila for its future application
van der Ark, K. C. H. (2018) · doi:10.18174/427507 · Cited by 10
Shalon, D., Culver, R. N., Grembi, J. A., Folz, J. S., Treit, P. V., Dethlefsen, L., Meng, X., Yaffe, E., Spencer, S. P., Shi, H., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.19.476920 · Cited by 8
Research progress on the correlation between intestinal flora and colorectal cancer
Wang, X., Zhang, Q., Xu, R., Li, X., & Hong, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1416806 · Cited by 7
“Moreover, many studies have reported varying levels of microbial metabolites in stool samples from patients with CRC, including unsaturated fatty acids, ursodeoxycholic acid, lower levels of butyric acid, and higher levels of acetic acid (129).”
BackgroundWu, Y., Shen, N., Hope, C., Noh, H. I., Richardson, B. N., Swartz, M. C., & Bai, J. (2017) · Beneficial Microbes · doi:10.1163/18762891-bja00026 · Cited by 11
Djouina, M., Waxin, C., Caboche, S., Dehaut, A., Himber, C., BALESDENT, C., Beury, D., Hot, D., Vignal, C., Launay, D., et al. (2025) · Environmental Research · doi:10.1016/j.envres.2025.122621 · Cited by 13
Kaushik, P., & Ahmad, R. S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102135 · Cited by 8
Xu, M., Qiu, X., Qiu, C., Yang, T., Xu, J., Chen, L., Shuai, L., Xu, Z., Cheng, X., Zhang, Y., et al. (2023) · Radiation Medicine and Protection · doi:10.1016/j.radmp.2023.02.001 · Cited by 7
Díaz-Corona, L. R., Parra‐Saavedra, K. J., Mora-Alonzo, R. S., Macías-Rodríguez, M. E., Martínez-Preciado, A. H., Guevara-Martínez, S. J., Zamudio‐Ojeda, A., & Macías-Lamas, A. M. (2023) · Separations · doi:10.3390/separations10050308 · Cited by 8
Sarkar, P., Kandimalla, R., Bhattacharya, A., Romi, W., Dehingia, M., Kalita, M. C., Talukdar, N. C., Talukdar, R., & Khan, M. R. (2023) · Microorganisms · doi:10.3390/microorganisms11061501 · Cited by 9
The short appendix vermiformis as a risk factor for colorectal cancer
Çakmak, Y. Ö., Ergelen, R., Ekinci, G., & Kaspar, E. Ç. (2014) · Clinical Anatomy · doi:10.1002/ca.22375 · Cited by 8
“Moreover, gut bacteria convert linoleic acids derived from vegetable oils into conjugated linoleic acids, which have the ability to inhibit carcinogenesis (Lee et al., 2005; McIntosh et al., 2009; Weir et al., 2013).”
BackgroundFecal Microbiota Differences According to the Risk of Advanced Colorectal Neoplasms
Yang, H., Kwon, M., Chang, Y., Song, S.-K., Ahn, K.-S., Kim, H., Yun, Y., Kim, H., & Park, D. I. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000979 · Cited by 8
Characterizing the cancer-associated microbiome with small RNA sequencing data
Lee, W.-H., Chen, K.-P., Wang, K., Huang, H., & Juan, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.166 · Cited by 7
Dietary Manipulation on Gut Microbiome in Patients with Diabetes and Colorectal cancer
Chu, N. H. S. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00667-8 · Cited by 6
“Nonetheless, there is ongoing debate regarding the role of Akkermansia muciniphila in bacterial overgrowth associated with colorectal carcinogenesis [41, 42], highlighting the importance of maintaining a delicate balance of microbial homeostasis and health [43].”
Bhattacharyya, N. K., Sastimoglu, Z., Armstrong, D., Selvaganapathy, P. R., & Deen, M. J. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110561 · Cited by 7
Multifaceted effects of the microbiome in pancreatic cancer: from association to modulation
Thomas, R. M. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01119-y · Cited by 6
“Studies that have characterized the bacterial gut microbiome through sequencing have reported a decrease in butyrate-producing bacteria in the gut microbiota of patients with PDAC compared with healthy individuals as controls 119,120 , which is consistent with other cancers 121–123 .”
Sylwestrzak, T., Ciosek, M., Pastuszak, K., & Jastrzębski, T. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14248949 · Cited by 9
“Weir et al. also observed a statistically significant decrease in the relative proportion of butyrate in CRC, though exact concentrations were not reported ( p < 0.05) [34].”
InfluentialRelationship of the mucin-degrading bacterium Akkermansia muciniphila with colorectal cancer
Karamzin, A. M., Ropot, A. V., & Евгеньевич, Б. Р. (2020) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-178-6-158-165 · Cited by 6
Metabolomic profiling for the preventive effects of dietary grape pomace against colorectal cancer
Wang, H., Tian, Q., Xu, Z., Du, ., & Zhu, M. J. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109308 · Cited by 8
dos Reis, S. A., Pelúzio, M. D. C. G., & Bressan, J. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3014 · Cited by 7
“Some studies observed that treatment with antimicrobials resulted in the increase of the Enterobacteriaceae family (Table 3), which comprises some species related to the increased risk of developing colorectal cancer.(46,47) As discussed earlier, the metabolites produced by the microbiota exert considerable influence…”
Result
Metadata
- Authors
- Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P.
- Affiliations
- Colorado State University (US)
- Agricultural Research Service (US)
- Corresponding author
- Weir, Tiffany L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-08-06
- Volume
- 8
- Issue
- 8
- Pages
- e70803
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3735522
- OpenAlex
- W2115450300
- Cited by
- 642
- References
- 48
- Citations by year
- 2026: 15 · 2025: 40 · 2024: 37 · 2023: 60 · 2022: 66 · 2021: 67 · 2020: 67 · 2019: 74 · 2018: 58 · 2017: 53 · 2016: 54 · 2015: 29 · 2014: 21 · 2013: 1
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Cancer Institute (R03CA150070)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- colorectal cancer, gut microbiota, Akkermansia muciniphila, butyrate, short-chain fatty acids, mucin degradation, ursodeoxycholic acid, bile acids, amino acids, polyunsaturated fatty acids, monounsaturated fatty acids, acetate, 16S rRNA gene, chemoprevention
- MeSH terms
- Adult, Aged, Aged, 80 and over, Carcinoma in Situ, Feces, Female, Health, Humans, Male, Middle Aged, Colorectal Neoplasms, Case-Control Studies, Metabolome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.